19
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is PROPRANOLOL HYDROCHLORIDE, with a corresponding application number 78703.
Regulatory Information RX
With a dosage strength 120MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2011-07-15
Therapeutic Equivalence (TE) Code AB
18
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is PROPRANOLOL HYDROCHLORIDE, with a corresponding application number 78703.
Regulatory Information RX
With a dosage strength 60MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2011-07-15
Therapeutic Equivalence (TE) Code AB
17
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is PROPRANOLOL HYDROCHLORIDE, with a corresponding application number 78703.
Regulatory Information RX
With a dosage strength 160MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2011-07-15
Therapeutic Equivalence (TE) Code AB
16
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is PROPRANOLOL HYDROCHLORIDE, with a corresponding application number 78703.
Regulatory Information RX
With a dosage strength 80MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2011-07-15
Therapeutic Equivalence (TE) Code AB